Sign In
Buy AXGN
$42.21
+0.86 (+2.08%)
At Close: Jul 31, 2026
AxoGen, Inc. (AXGN) CEO Karen Zaderej on Q1 2020 Results - Earnings Call Transcript
08:11am, Friday, 08'th May 2020
AxoGen, Inc. (NASDAQ:AXGN) Q1 2020 Earnings Conference Call May 06, 2020 16:30 A.M. ET Company Participants Karen Zaderej - Chairman, President, and CEO Peter J
AxoGen Inc (AXGN) Q1 2020 Earnings Call Transcript
04:00pm, Thursday, 07'th May 2020
Joining me on today's call is Karen Zaderej, AxoGen's Chairman, Chief Executive Officer and President. Karen will begin our call with an overview of our Q1 performance, our response to the COVID-19 p
U.S. RESEARCH ROUNDUP-Ashland Global, Lyft, Solaredge Technologies
03:19pm, Thursday, 07'th May 2020
Wall Street securities analysts on Thursday revised their ratings and
price targets on several U.S.-listed companies, including Ashland Global Holdings, Lyft and
Solaredge Technologies.
HIGH
Canaccord Genuity Downgrades Axogen to Hold, Announces $12 Price Target
11:28am, Thursday, 07'th May 2020Edited Transcript of AXGN earnings conference call or presentation 6-May-20 8:30pm GMT
08:35am, Thursday, 07'th May 2020
Q1 2020 AxoGen Inc Earnings Call
U.S. RESEARCH ROUNDUP-Ashland Global Holdings, Lyft, Solaredge Technologies
07:34am, Thursday, 07'th May 2020
Wall Street securities analysts revised their ratings and price targets on
several U.S.-listed companies, including Ashland Global Holdings, Lyft and Solaredge
Technologies, on Thursday.
HIG
Axogen Q1 EPS $(0.190) Misses $(0.150) Estimate, Sales $24.300M Miss $26.190M Estimate
08:19pm, Wednesday, 06'th May 2020Axogen, Inc. Reports First Quarter 2020 Financial Results
08:01pm, Wednesday, 06'th May 2020
ALACHUA, Fla., May 06, 2020 -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today.
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
AxoGen (NASDAQ:AXGN) Upgraded by BidaskClub to Hold
09:38am, Thursday, 30'th Apr 2020
AxoGen (NASDAQ:AXGN) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Thursday, BidAskClub reports. AXGN has been the topic of a number of othe
